View Single Post
Old 07-14-2012, 10:50 PM   #2
marvass
Senior Member
 
Join Date: May 2012
Posts: 105
Re: review of current knowledge of breast cancer brain mets (especially her2+)

Thanks lani,
Very interesting report, which I think is missing the more effective intrathecal trastuzumab. In my opinion when advance BC her2+ patients are taking adjuvent intraveneous trastuzumab they should also take it intrathecally, since the occurrence of brain mets is high. And it seems that nobody is studying this. Amazing.

Mario
marvass is offline   Reply With Quote